Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Immunocore Holdings Plc ADR
(NQ:
IMCR
)
35.76
+0.16 (+0.45%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Immunocore Holdings Plc ADR
< Previous
1
2
Next >
Immunocore to present at upcoming investor conferences
June 01, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore Reports First Quarter 2023 Financial Results and Provides Business Update
May 10, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore to present at the Bank of America Securities 2023 Health Care Conference
May 03, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore presents new KIMMTRAK data confirming association between early ctDNA reduction and longer overall survival
April 18, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore to present at the 22nd Annual Needham Virtual Healthcare Conference
April 11, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore to present four posters at AACR Annual Meeting 2023
March 14, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore Reports 2022 Financial Results and Provides Business Update
March 01, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore to present at upcoming investor conferences
February 28, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore to Report Fourth Quarter and Full Year 2022 Earnings and Host Call on March 1, 2023
February 23, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore announces initial Phase 1 safety and pharmacodynamic activity data with first soluble TCR therapy for people living with HIV
February 22, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Is Biotech Immunocore About To Make A 25% Price Move?
February 07, 2023
Small-cap Immunocore has been a price leader within the biotech industry. Analysts have a "buy" rating on the stock and estimate that it will move 25% higher.
Via
MarketBeat
Topics
ETFs
Immunocore to present at upcoming investor conferences
February 01, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore announces strategic priorities including pipeline expansion for 2023 -2024
January 09, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore to present at the 41st Annual J.P. Morgan Healthcare Conference
January 04, 2023
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore is awarded the Prix Galien France award for KIMMTRAK
December 15, 2022
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore presents ovarian cancer expansion data for ImmTAC® candidate IMC-C103C targeting MAGE-A4
December 08, 2022
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore and Gadeta Announce Agreement to Develop First Gamma Delta (γδ) TCR ImmTAC for Solid Tumors
December 02, 2022
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore to present at the 5th Annual Evercore ISI HealthCONx Conference
November 23, 2022
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore presents new biomarker analysis for KIMMTRAK (tebentafusp-tebn) in metastatic uveal melanoma at the SITC 2022 Annual Meeting
November 11, 2022
From
Immunocore Holdings Limited
Via
GlobeNewswire
Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
November 11, 2022
Neurocrine Biosciences trended higher with the broad market Thursday, coming within a penny of Tuesday’s high of $125.99. It is forming a bullish channel.
Via
MarketBeat
Immunocore to present at the Jefferies London Healthcare Conference
November 10, 2022
From
Immunocore Holdings Limited
Via
GlobeNewswire
Immunocore Reports Third Quarter 2022 Financial Results and Provides Business Update
November 09, 2022
From
Immunocore Holdings Limited
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.